Behzad Khallaghi1, Fatemeh Safarian1, Sanaz Nasoohi2, Abolhassan Ahmadiani1, Leila Dargahi3. 1. Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. NeuroBiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: l.dargahi@sbmu.ac.ir.
Abstract
AIMS: Reactive oxygen species have been recognized to impair cell function through suppressing Akt the well-known pro-survival molecule. Pile of concrete evidence imply metformin as an Insulin sensitizer may enhance Akt/mTOR activity however the significance of Akt/mTOR recruitment has not yet been revealed in metformin induced neuroprotection against oxidative stress. MAIN METHODS: In the current study using H2O2 induced injury in PC12 cells; we first examined metformin impact on cell death by MTT assay and visual assessment. Metformin pretreated cells were then subjected to immunoblotting as well as real time PCR to find PI3K, Akt, mTOR and S6K concurrent transcriptional and post-transcriptional changes. The proportions of phosphorylated to non-phosphorylated constituents of PI3K/Akt/mTOR/S6K were determined to address their activation upon metformin treatment. KEY FINDINGS: According to cells morphology and MTT data metformin led to significant protection against H2O2 induced injury in 0.1 and 0.5mM concentrations. Metformin induced protection concurred with elevated PI3K/Akt/mTOR/S6K activity as well as enhanced GSH levels. These changes paralleled with a profound decline in the corresponding transcripts as determined by real time PCR. SIGNIFICANCE: Taken together our experimentation supports the hypothesis that Akt/mTOR/S6K cascade may contribute to metformin alleviating effect. The present work while highlighting metformin anti-oxidant characteristics, concludes that Akt/mTOR signaling might be central to the drug's alleviating effects.
AIMS: Reactive oxygen species have been recognized to impair cell function through suppressing Akt the well-known pro-survival molecule. Pile of concrete evidence imply metformin as an Insulin sensitizer may enhance Akt/mTOR activity however the significance of Akt/mTOR recruitment has not yet been revealed in metformin induced neuroprotection against oxidative stress. MAIN METHODS: In the current study using H2O2 induced injury in PC12 cells; we first examined metformin impact on cell death by MTT assay and visual assessment. Metformin pretreated cells were then subjected to immunoblotting as well as real time PCR to find PI3K, Akt, mTOR and S6K concurrent transcriptional and post-transcriptional changes. The proportions of phosphorylated to non-phosphorylated constituents of PI3K/Akt/mTOR/S6K were determined to address their activation upon metformin treatment. KEY FINDINGS: According to cells morphology and MTT data metformin led to significant protection against H2O2 induced injury in 0.1 and 0.5mM concentrations. Metformin induced protection concurred with elevated PI3K/Akt/mTOR/S6K activity as well as enhanced GSH levels. These changes paralleled with a profound decline in the corresponding transcripts as determined by real time PCR. SIGNIFICANCE: Taken together our experimentation supports the hypothesis that Akt/mTOR/S6K cascade may contribute to metformin alleviating effect. The present work while highlighting metformin anti-oxidant characteristics, concludes that Akt/mTOR signaling might be central to the drug's alleviating effects.
Authors: Yuri V Nikitchenko; Vladimir K Klochkov; Nataliya S Kavok; Nina A Karpenko; Irina V Nikitchenko; Svetlana L Yefimova; Anatoly I Bozhkov Journal: Biol Trace Elem Res Date: 2021-04-26 Impact factor: 3.738
Authors: Magdalena Markowicz-Piasecka; Joanna Sikora; Aleksandra Szydłowska; Agata Skupień; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen Journal: Pharm Res Date: 2017-06-06 Impact factor: 4.200
Authors: Laura Poupon-Bejuit; Eridan Rocha-Ferreira; Claire Thornton; Henrik Hagberg; Ahad A Rahim Journal: Front Cell Neurosci Date: 2020-05-06 Impact factor: 5.505